Related Experiment Video

Updated: Jun 30, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

The von Hippel-Lindau gene: turning discovery into therapy

Peter E Clark1, Michael S Cookson

  • 1Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232-2765, USA. Peter.clark@vanderbilt.edu

Cancer
|September 19, 2008
PubMed

Insights

Discoveries about the von Hippel-Lindau (VHL) gene have revolutionized kidney cancer treatment. Understanding VHL gene function led to targeted therapies for advanced renal cell carcinoma, transforming patient management.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Mutations in the von Hippel-Lindau (VHL) gene are implicated in hereditary VHL syndrome and most sporadic clear cell renal cell carcinomas.
  • The VHL gene plays a critical role in cellular oxygen sensing and tumor suppression.

Purpose of the Study:

  • To review the journey of the VHL gene from discovery to its impact on renal cell carcinoma therapeutics.
  • To highlight how basic science discoveries translate into clinical advancements for kidney cancer.

Main Methods:

  • Literature review tracing the history of VHL gene research.
  • Analysis of the VHL gene's biologic function and its role in tumorigenesis.
  • Examination of the development of targeted therapies based on VHL gene understanding.

Main Results:

  • The cloning and functional elucidation of the VHL gene.
  • Identification of VHL gene aberrations as a key driver in clear cell renal cell carcinoma.
  • Development of novel targeted treatments for advanced kidney cancer.

Conclusions:

  • The VHL gene discovery exemplifies the bench-to-bedside translation of scientific findings.
  • Understanding VHL gene function has fundamentally altered the management of advanced renal cell carcinoma.
  • Targeted therapies based on VHL gene knowledge represent a paradigm shift in kidney cancer treatment.

More Related Videos

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor07:16

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor

Published on: September 13, 2018

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.